GARDEN CITY, N.Y., May 21, 2014 /PRNewswire/ -- Millennium HealthCare Inc. (OTCBB: MHCC) today announced the continued expansion of its distribution network, positioning the Company to become a leading distributor of medical devices for preventative care and early detection of serious medical issues. Millennium, through its wholly owned operating subsidiary Millennium Medical Devices, LLC, provides primary care physician practices, physician groups and healthcare facilities of all sizes with cutting edge medical devices such as the VasoScan Cardiovascular Assessment Test, the OralCDX Brush Biopsy Test and the DermCDx Biopsy test. There are over 400,000 primary care physicians in the United States who could utilize these tests in their practices.
Millennium Medical Devices has signed a Network Selling Agreement with a US based healthcare organization for an additional 300 locations, bringing the total locations in the Company's distribution network to 1,300. As with the previously announced contracts, this agreement includes an average monthly minimum use of 350 units per location, per device.
"We are thrilled by the enthusiastic response of the primary care community to our innovative products. We continue to introduce VasoScan, OralCDx and DermCDx utilizing a contracted use model, which provides us with a unique opportunity to accelerate market penetration," said Chris Amandola, President of Millennium Healthcare.
About Millennium HealthCare Inc.
Millennium HealthCare Inc. through its wholly owned operating subsidiaries provides primary care physician practices, physician groups and healthcare facilities of all sizes with cutting edge medical devices focused primarily on preventive care through early detection. The Company also provides advanced billing and coding services and practice development and management services.
Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995
This press release contains certain statements that may constitute "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995 (the "Reform Act"). Forward-looking statements are identified by such words and phrases as "we expect," "expected to," "estimates," "estimated," "current outlook," "we look forward to," "would equate to," "projects," "projections," "projected to be," "anticipates," "anticipated," "we believe," "could be," and other similar phrases. All statements addressing operating performance, events, or developments that we expect or anticipate will occur in the future, including statements relating to revenue growth, earnings, earnings-per-share growth, or similar projections, are forward-looking statements within the meaning of the Reform Act. Because they are forward-looking, they should be evaluated in light of important risk factors that could cause our actual results to differ materially from our anticipated results. The information provided in this document is based upon the facts and circumstances known at this time. We undertake no obligation to update these forward-looking statements after the date of this release.
Media Relations Contact:
Pillar Marketing Group, Inc.
SOURCE Millennium HealthCare Inc.